Volumina Medical is the 28th start-up winner of the Prix Strategis!
Last night, the 28th winning start-up of the Prix Strategis was revealed among the 111 candidates who participated in this 2021 edition. Volumina Medical, an innovative start-up in the field of reconstructive surgery, develops regenerative and degradable implants for minimally invasive breast reconstruction. It won the 50,000 Swiss francs prize after attracting the jury's attention with the quality of its promising invention.
Founded in 2018 at EPFL, the company offers a solution for breast cancer patients who need a repair after a breast removal. The implant developed by this EPFL spin-off is an injectable solution that allows the breast to regenerate naturally while avoiding an invasive hospital procedure. The first product in development has already been endorsed by more than 70 plastic surgeons worldwide and by breast cancer patients. Patients see the hope of a return to their natural physical form and, moreover, the possibility of psychological reconstruction after a difficult experience.
Neurosoft Bioelectronics rounds out the podium in second place. Also in the medical field, this start-up aims to replace the way we connect to the nervous system to offer better therapies to patients suffering from severe neurological disorders. Neurosoft develops flexible and elastic implants that interact seamlessly with the nervous system.
On the third step of the podium, we find the start-up Bloom Biorenewables, which uncovers the hidden value of biomass to provide energy and renewable products. It offers a solution that is both sustainable and affordable.
Off the podium, but no less deserving, we find Backbone, which offers the first platform to order any type of imagery, and Dagsmejan, which develops functional sleepwear to improve sleep quality.
Finally, the guests present at the ceremony, as well as all the people interested in these start-ups on social networks, could crown Neurosoft Bioelectronics with La Mobilière's Public Prize.
For this 28th edition, we were honored to have Dan Staner, Vice President and Head of Europe, Middle East & Africa from Moderna as our guest speaker. His speech allowed us to understand the full potential of the mRNA vaccines that Moderna has been developing for several years and that have been crucial in the fight against the current pandemic.
The Prix Strategis is organized by HEC Espace Entreprise, an association of students who want to bring together the entrepreneurial world and the students of HEC Lausanne. Finally, we would like to compliment Alexandre Keusen, Head of the Prix Strategis, for organizing this challenging event, as well as the entire team that accompanied him to offer us this closing ceremony.
Photo: Innovation Time Lausanne
